ObsEva SA
Developed novel therapeutics for women's reproductive health and pregnancy.
OBSN | SW
Overview
Corporate Details
- ISIN(s):
- CH1260041939
- LEI:
- 549300PNZ0UEJVKN1618
- Country:
- Switzerland
- Address:
- CHEMIN DES AULX 12, 1228 PLAN-LES-OUATES
- Website:
- https://www.obseva.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ObsEva SA is a clinical-stage biopharmaceutical company that was focused on the development and commercialization of novel therapeutics for women's reproductive health and pregnancy. Founded in 2012, the company's research centered on treatments for serious conditions from conception to birth, such as preterm labor. In February 2024, the company announced it was winding down its operations. Note: The provided sources contain conflicting information, identifying the company's industry as biopharmaceutical, not financial data services, and including unrelated content from a sports streaming website.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ObsEva SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ObsEva SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ObsEva SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-17 | N/A | Non-Executive member | Buy | None | 2,058.00 CHF |
| 2022-03-16 | N/A | Non-Executive member | Buy | None | 27,010.00 CHF |
| 2022-03-15 | N/A | Non-Executive member | Buy | None | 23,642.00 CHF |
| 2022-02-08 | N/A | Non-Executive member | Buy | None | 64,161.00 CHF |
| 2022-02-01 | N/A | Non-Executive member | Buy | None | 70,716.00 CHF |
| 2022-01-24 | N/A | Non-Executive member | Buy | None | 69,748.00 CHF |
| 2022-01-11 | N/A | Non-Executive member | Buy | None | 183,535.00 CHF |
| 2022-01-10 | N/A | Non-Executive member | Buy | None | 177,643.00 CHF |
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
